Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.03
- Piotroski Score 4.00
- Grade Outperform
- Symbol (QDEL)
- Company QuidelOrtho Corporation
- Price $45.52
- Changes Percentage (3.03%)
- Change $1.34
- Day Low $44.76
- Day High $45.98
- Year High $75.86
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $110.00
- High Stock Price Target $125.00
- Low Stock Price Target $50.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$26.38
- Trailing P/E Ratio -1.58
- Forward P/E Ratio -1.58
- P/E Growth -1.58
- Net Income $-10,100,000
Income Statement
Quarterly
Annual
Latest News of QDEL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Should You Sell QuidelOrtho Corporation (QDEL)?
Chartwell Investment Partners, LLC, released the Carillon Chartwell Small Cap Growth Fund investor letter for the first quarter of 2024, discussing the U.S. economy, future economic trends, and highli...
By Yahoo! Finance | 3 months ago -
What Made The Brown Capital Management Small Company Fund to Sell QuidelOrtho Corporation (QDEL)?
Brown Capital Management's Small Company Fund underperformed in Q1 2024 due to market shifts. QuidelOrtho Corporation was highlighted, showing a decline in stock value and revenue. The fund focuses on...
By Yahoo! Finance | 3 months ago -
QuidelOrtho Corporation (QDEL) is Excited about the New Product Launch
Meridian Funds, managed by ArrowMark Partners, reported a 6.04% return for the Meridian Small Cap Growth Fund in Q1 2024. The fund's top holdings, including QuidelOrtho Corporation, were discussed in ...
By Yahoo! Finance | 3 months ago
